Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes.
暂无分享,去创建一个
Marco Proietti | Gregory Y H Lip | G. Lip | K. Senoo | Qinmei Xiong | Keitaro Senoo | Q. Xiong | Marco Proietti
[1] G. Lip,et al. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. , 2013, International journal of cardiology.
[2] G. Lip,et al. Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP‐AF audit tool , 2015, International journal of clinical practice.
[3] Robert Safford,et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. , 2005, American heart journal.
[4] T. Uejima,et al. Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[5] G. Lip,et al. Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. , 2014, QJM : monthly journal of the Association of Physicians.
[6] G. Lip,et al. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. , 2012, International journal of cardiology.
[7] Luigi Tavazzi,et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. , 2015, The American journal of medicine.
[8] David M Herrington,et al. Atrial fibrillation and the risk of myocardial infarction. , 2015, JAMA internal medicine.
[9] Motoyuki Nakamura,et al. Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation. , 2010, International heart journal.
[10] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[11] Mark D. Huffman,et al. AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .
[12] S. Lévy,et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. , 2007, Journal of the American College of Cardiology.
[13] Frank Beckers,et al. Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.
[14] M. Razavi,et al. "Asymptomatic" persistent or permanent atrial fibrillation: A misnomer in selected patients. , 2015, International journal of cardiology.
[15] H. Crijns,et al. Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study. , 2014, Heart rhythm.
[16] T. Chao,et al. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. , 2014, Heart rhythm.
[17] G. Lip,et al. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[18] Julie Redfern,et al. Screening to identify unknown atrial fibrillation , 2013, Thrombosis and Haemostasis.
[19] S. Suissa,et al. Incidence, Mortality, and Sex Differences of Non‐Valvular Atrial Fibrillation: A Population‐Based Study , 2014, Journal of the American Heart Association.